Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.
Press releases published on June 23, 2025
HFMA Announces Kiran Batheja as National Chair
GlobeNewswire
·
June 23, 2025
DENVER, June 23, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today during its annual conference inducted Kiran N. Batheja, FHFMA, into office as its National Chair, effective June 1, 2025. Batheja is a seasoned …
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
GlobeNewswire
·
June 23, 2025
CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, is pleased to announce the appointment of Dr. Michael Mahler as Chief Scientific Officer. With an extensive background in …
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer with KRAS G12 Mutations
GlobeNewswire
·
June 23, 2025
Breakthrough Therapy Designation based on promising early clinical evidence observed with daraxonrasib in patients with pancreatic ductal adenocarcinoma (PDAC) RASolute 302, a Phase 3 registrational study of daraxonrasib in patients with previously treated …
Cepham Calls on Natural Products Industry to Lead a Precision Wellness Revolution for Men
GlobeNewswire
·
June 23, 2025
SOMERSET, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- As the conversation around men’s health evolves, Cepham is leading a call to action for the natural products industry to rethink how it supports men through every stage of life—far beyond testosterone and …
Beyond Slim® Launches The Gut Gummy™ — A Direct-to-Consumer Wellness Brand Revolutionizing Gut Health
GlobeNewswire
·
June 23, 2025
Scottsdale, Arizona, June 23, 2025 (GLOBE NEWSWIRE) -- Beyond Slim®, a leader in functional wellness …
Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
June 23, 2025
June 23, 2025 Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a …
Electronic Lab Notebook Market worth US$1.03 billion by 2030 with 7.3% CAGR | MarketsandMarkets™.
GlobeNewswire
·
June 23, 2025
Delray Beach, FL, June 23, 2025 (GLOBE NEWSWIRE) -- The global electronic lab notebook market, valued at US$0.68 billion in 2024 stood at US$0.72 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a …
NetraMark's AI Significantly Outperforms ChatGPT, DeepSeek and Traditional Machine Learning in Clinical Trial Subpopulation Discovery, Offers New Path for Trial Success
GlobeNewswire
·
June 23, 2025
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials has released a new preprint on …
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
GlobeNewswire
·
June 23, 2025
SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced the results from two large-scale real-world studies presented at the American Diabetes Association’s 85th Scientific Sessions (ADA 2025). The analyses …
Biomarkers Market worth US$104.15 billion in 2030 with 10.8% CAGR | MarketsandMarkets™.
GlobeNewswire
·
June 23, 2025
Delray Beach, FL, June 23, 2025 (GLOBE NEWSWIRE) -- The global biomarkers market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted …
Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program
GlobeNewswire
·
June 23, 2025
The significant HYPE token position, acquired at an average price of approximately $34 per token, makes Eyenovia the first Nasdaq listed company to run a validator on Hyperliquid FDA registration of the Optejet User Filled Device (UFD) on track for …
NKGen Biotech Announces International and U.S. Expansion of Phase 1/2a Troculeucel Alzheimer’s Trial with Activation of Clinical Sites in Canada and Florida
GlobeNewswire
·
June 23, 2025
SANTA ANA, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Firefly Neuroscience to be Added to the Russell Microcap® Index
GlobeNewswire
·
June 23, 2025
– Comes less than a year after listing on Nasdaq – KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that …
Ashvattha Therapeutics Reports the Ability to Tune Nanomedicines to Image Neuroinflammation in Multiple Sclerosis Patients and Tumor Associated Macrophages in Cancer at SNMMI Annual Meeting
GlobeNewswire
·
June 23, 2025
Novel nanomedicine radiotracer crosses blood brain barrier in patients with neuroinflammation Tumor macrophage radiotracer achieves 41.6% peak tumor uptake in preclinical studies REDWOOD CITY, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Ashvattha …
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer
GlobeNewswire
·
June 23, 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development …
Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases
GlobeNewswire
·
June 23, 2025
PARMA, Italy, June 23, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced the recipients of its "Find For …
Optime Care Partners with Tilde Sciences as Exclusive Specialty Pharmacy Provider for Vecamyl
GlobeNewswire
·
June 23, 2025
ST. LOUIS, June 23, 2025 (GLOBE NEWSWIRE) -- Optime Care, AscellaHealth’s Specialty Pharmacy, is pleased to announce an expanded partnership with Tilde Sciences LLC (“Tilde”), effective June 23, 2025. Under this arrangement, Optime Care will serve as the …
Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA)
GlobeNewswire
·
June 23, 2025
Oral presentation highlighted the post-hoc analysis during the “Interventions to Prevent Hypoglycemia: Bench to Bedside” session Treatment with sotagliflozin resulted in no increased risk and a reduction in hypoglycemia events, particularly in patients …
ORYZON Announces Submission of Phase III Protocol to FDA to Initiate PORTICO-2 Trial of Vafidemstat in Borderline Personality Disorder (BPD) Patients
GlobeNewswire
·
June 23, 2025
PORTICO-2 designed to validate vafidemstat’s efficacy in reducing aggression in BPD patients Primary endpoint: STAXI-2 Trait Anger (patient-reported) Key secondary endpoint: Overt Aggression Scale-Modified (OAS-M) (clinician-rated) Additional secondary …
AnswersNow CEO and Founder Jeff Beck Named EY Entrepreneur of the Year®2025 Mid-Atlantic Award Winner
GlobeNewswire
·
June 23, 2025
RICHMOND, Va., June 23, 2025 (GLOBE NEWSWIRE) -- AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today announced that Ernst …